193 related articles for article (PubMed ID: 9665499)
1. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
Walli R; Reinhart B; Luckow B; Lederer E; Loch O; Malo A; Wank R; Schlöndorff D; Goebel FD
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):229-33. PubMed ID: 9665499
[TBL] [Abstract][Full Text] [Related]
2. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
[TBL] [Abstract][Full Text] [Related]
3. Association between CCR5 genotype and the clinical course of HIV-1 infection.
de Roda Husman AM; Koot M; Cornelissen M; Keet IP; Brouwer M; Broersen SM; Bakker M; Roos MT; Prins M; de Wolf F; Coutinho RA; Miedema F; Goudsmit J; Schuitemaker H
Ann Intern Med; 1997 Nov; 127(10):882-90. PubMed ID: 9382366
[TBL] [Abstract][Full Text] [Related]
4. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
5. Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.
Wang C; Abdel-Mohsen M; Strain MC; Lada SM; Yukl S; Cockerham LR; Pilcher CD; Hecht FM; Sinclair E; Liegler T; Richman DD; Deeks SG; Pillai SK
J Infect Dis; 2014 Dec; 210(11):1838-43. PubMed ID: 24935955
[TBL] [Abstract][Full Text] [Related]
6. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission.
Ometto L; Zanchetta M; Mainardi M; De Salvo GL; Garcia-Rodriguez MC; Gray L; Newell ML; Chieco-Bianchi L; De Rossi A
AIDS; 2000 Aug; 14(12):1721-9. PubMed ID: 10985308
[TBL] [Abstract][Full Text] [Related]
7. Relationship between CCR5
Martínez-Bonet M; González-Serna A; Clemente MI; Morón-López S; Díaz L; Navarro M; Puertas MC; Leal M; Ruiz-Mateos E; Martinez-Picado J; Muñoz-Fernández MA
Clin Microbiol Infect; 2017 May; 23(5):318-324. PubMed ID: 28042001
[TBL] [Abstract][Full Text] [Related]
8. HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.
Katzenstein TL; Eugen-Olsen J; Hofmann B; Benfield T; Pedersen C; Iversen AK; Sørensen AM; Garred P; Koppelhus U; Svejgaard A; Gerstoft J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):10-4. PubMed ID: 9377119
[TBL] [Abstract][Full Text] [Related]
9. Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.
Marmor M; Sheppard HW; Donnell D; Bozeman S; Celum C; Buchbinder S; Koblin B; Seage GR;
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):472-81. PubMed ID: 11511825
[TBL] [Abstract][Full Text] [Related]
10. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection.
Romiti ML; Colognesi C; Cancrini C; Mas A; Berrino M; Salvatori F; Orlandi P; Jansson M; Palomba E; Plebani A; Bertran JM; Hernandez M; de Martino M; Amoroso A; Tovo PA; Rossi P; Espanol T; Scarlatti G
Mol Med; 2000 Jan; 6(1):28-36. PubMed ID: 10803406
[TBL] [Abstract][Full Text] [Related]
12. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.
Clegg AO; Ashton LJ; Biti RA; Badhwar P; Williamson P; Kaldor JM; Stewart GJ
AIDS; 2000 Jan; 14(2):103-8. PubMed ID: 10708279
[TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic expressions of CCR5-delta32/delta32 homozygosity.
Nguyêñ GT; Carrington M; Beeler JA; Dean M; Aledort LM; Blatt PM; Cohen AR; DiMichele D; Eyster ME; Kessler CM; Konkle B; Leissinger C; Luban N; O'Brien SJ; Goedert JJ; O'Brien TR
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):75-82. PubMed ID: 10534150
[TBL] [Abstract][Full Text] [Related]
15. [CCR5-Δ32 allele involvement in the clinical evolution of HIV1+ patients in Yucatán, Mexico].
Valadez-González N; González-Martínez P; Lara-Perera D; Vera-Gamboa L; Góngora-Biachi R
Salud Publica Mex; 2011; 53(6):463-8. PubMed ID: 22282138
[TBL] [Abstract][Full Text] [Related]
16. CCR5 genotypes and progression to HIV disease in perinatally infected children.
de Angelis DS; Freire WS; Pannuti CS; Succi RC; Machado DM
Braz J Infect Dis; 2007 Apr; 11(2):196-8. PubMed ID: 17625759
[TBL] [Abstract][Full Text] [Related]
17. The influence of MT-2 tropism on the prognostic implications of the delta32 deletion in the CCR-5 gene.
Bratt G; Sandström E; Albert J; Samson M; Wahren B
AIDS; 1997 Oct; 11(12):1415-9. PubMed ID: 9342063
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
Morawetz RA; Rizzardi GP; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser MP; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
Eur J Immunol; 1997 Dec; 27(12):3223-7. PubMed ID: 9464809
[TBL] [Abstract][Full Text] [Related]
19. Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.
Henrich TJ; Hanhauser E; Hu Z; Stellbrink HJ; Noah C; Martin JN; Deeks SG; Kuritzkes DR; Pereyra F
AIDS; 2015 May; 29(8):867-76. PubMed ID: 25730507
[TBL] [Abstract][Full Text] [Related]
20. A subset of human immunodeficiency virus type 1 long-term non-progressors is characterized by the unique presence of ancestral sequences in the viral population.
Bello G; Casado C; Sandonis V; Alonso-Nieto M; Vicario JL; García S; Hernando V; Rodríguez C; Romero JD; López-Galíndez C
J Gen Virol; 2005 Feb; 86(Pt 2):355-364. PubMed ID: 15659755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
